3Indexed trials
drug · Product Intelligence
Baricitinib
Pipeline Intelligence
Baricitinib: 3 indexed trials, 3 sponsors; 5 linked Orange Book patents and 3 FDA-linked events where matched.
3Sponsors
5Orange Book patent links
3FDA-linked events
Development evidence
NCT01490632Eli Lilly and Company · out_of_scopePHASE2
NCT05189106Massachusetts General Hospital · alzheimersPHASE1, PHASE2
NCT05792462Tianjin Medical University General Hospital · multiple_sclerosisPHASE1
FDA / patent evidence
11045474OLUMIANT · app 2079242032-11-30
9089574OLUMIANT · app 2079242032-11-30
8158616OLUMIANT · app 2079242032-05-31
11806555OLUMIANT · app 2079242031-11-02
9737469OLUMIANT · app 2079242031-11-02
Regulatory context
FDA_APPROVALOLUMIANT · 2025-08-08
FDA_APPROVALBARICITINIB · 2024-07-22
FDA_APPROVALOLUMIANT · 2022-05-10
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.